ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
62,261.94
-0.12%
S&P 500
5,187.70
0.13%
Dow Jones
38,884.26
0.08%
US Dollar vs Yen
155.473
0.47%
Brent Oil
81.675
-1.44%
Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. EXACT Sciences Corporation (EXAS)

  7. EXACT Sciences Corporation (EXAS) ニュース

EXAS

EXACT Sciences (EXAS)

EXACT Sciences Corporation
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:EXAS
日付受信時刻ニュースソース見出しコード企業名
2024/05/0721 : 00Business WireExact Sciences Demonstrates Continued Scientific Advancement in Colorectal Cancer Screening with Multiple Data Presentations at DDW® 2024NASDAQ:EXASEXACT Sciences Corporation
2024/05/0119 : 00Business WireExact Sciences to Participate in May Investor ConferenceNASDAQ:EXASEXACT Sciences Corporation
2024/04/1519 : 00Business WireExact Sciences Names Aaron Bloomer as New Chief Financial OfficerNASDAQ:EXASEXACT Sciences Corporation
2024/04/1119 : 00Business WireExact Sciences Announces Debt Exchange Transaction and Private Placement of Convertible Senior NotesNASDAQ:EXASEXACT Sciences Corporation
2024/04/0901 : 05Business WireExact Sciences to Present Late-Breaking Data from ASCEND-2 Study Validating Its Investigational Multi-Cancer Early Detection Test at AACR Annual Meeting 2024NASDAQ:EXASEXACT Sciences Corporation
2024/04/0819 : 00Business WireExact Sciences Schedules First Quarter 2024 Earnings CallNASDAQ:EXASEXACT Sciences Corporation
2024/04/0419 : 05Business WireExact Sciences to Provide Mayo Clinic Patients with Individualized Cancer Tumor Information to Inform TreatmentNASDAQ:EXASEXACT Sciences Corporation
2024/03/2819 : 00Business WireExact Sciences Advances Development of Non-Endoscopic Oncoguard® Esophagus Test to Screen for Esophageal Cancer and Pre-CancerNASDAQ:EXASEXACT Sciences Corporation
2024/03/2721 : 05Business WireExact Sciences Named 2024 Gallup Exceptional Workplace Award WinnerNASDAQ:EXASEXACT Sciences Corporation
2024/03/1406 : 03Business WireThe New England Journal of Medicine Publishes Cologuard Plus™ Test Results from Pivotal BLUE-C StudyNASDAQ:EXASEXACT Sciences Corporation
2024/03/0721 : 59Business WireExact Sciences and Basketball Great Jamal Mashburn Encourage Americans 45+ to Have a Game Plan Against Colon CancerNASDAQ:EXASEXACT Sciences Corporation
2024/03/0510 : 42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EXASEXACT Sciences Corporation
2024/03/0510 : 42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EXASEXACT Sciences Corporation
2024/03/0510 : 41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EXASEXACT Sciences Corporation
2024/03/0510 : 40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EXASEXACT Sciences Corporation
2024/03/0510 : 39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EXASEXACT Sciences Corporation
2024/03/0510 : 38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EXASEXACT Sciences Corporation
2024/03/0510 : 38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EXASEXACT Sciences Corporation
2024/03/0510 : 37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EXASEXACT Sciences Corporation
2024/03/0510 : 36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EXASEXACT Sciences Corporation
2024/03/0205 : 53Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EXASEXACT Sciences Corporation
2024/03/0205 : 51Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EXASEXACT Sciences Corporation
2024/03/0205 : 33Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EXASEXACT Sciences Corporation
2024/03/0205 : 33Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EXASEXACT Sciences Corporation
2024/03/0205 : 28Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EXASEXACT Sciences Corporation
2024/03/0205 : 23Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EXASEXACT Sciences Corporation
2024/03/0205 : 22Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EXASEXACT Sciences Corporation
2024/03/0203 : 47Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EXASEXACT Sciences Corporation
2024/03/0201 : 10Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EXASEXACT Sciences Corporation
2024/02/2909 : 38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EXASEXACT Sciences Corporation
 Showing the most relevant articles for your search:NASDAQ:EXAS

最近閲覧した銘柄

SPI
SP500
S&P 500
USI
USTECH100
US Tech 100
USOTC
BNPQY
BNP Paribas (QX)
NASDAQ
AAPL
Apple
NASDAQ
TSLA
Tesla
NYSE
JPM
JP Morgan Chase
NASDAQ
QQQ
Invesco QQQ Trust Series 1
AMEX
XLV
Health Care Select Sector
AMEX
SPY
SPDR S&P 500
CCOM
US100
US Tech 100
FX
USDGBP
US Dollar vs Sterling
NYSE
AXP
American Express
CCOM
US30
US 30
USOTC
RHHBY
Roche (QX)
AMEX
XLF
Financial Select Sector
NYSE
MCD
McDonalds
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有